EUVIMEDEUVIMED entdecken
Fallbericht

CFTR modulators reduce acute pancreatitis episodes in individuals with CFTR-related disorders: A case series

Mitchell L Ramsey, Maria Corzo, Rosara Bass, Luis F Lara, Phil A Hart, A Jay Freeman

Journal of Cystic Fibrosis · 2026-05 · 25 (3) · 502-503

DOI: 10.1016/j.jcf.2026.01.008 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cystic Fibrosis, 2026-05. Verfasst von Mitchell L Ramsey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition; College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Div…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Pancreatitis, Chloride Channel Agonists. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators (CFTRm) reduce the frequency of recurrent acute pancreatitis (RAP) among individuals with pancreas sufficient cystic fibrosis (PS-CF), but the impact on RAP among individuals with CFTR-related disorder (CFTR-RD) is unknown. CFTRm are thought to be similarly effective in CFTR-RD because the mechanism of AP is identical to PS-CF. However, there are limited reports of CFTRm for CFTR-RD in the literature. We present the case histories of three individuals with RAP due to CFTR-RD who commenced treatment with CFTRm. Including 8.5 person-years of follow up, there have been no additional AP episodes during treatment and all individuals have tolerated treatment very well. This report indicates that CFTRm are effective in reducing AP frequency in some individuals with RAP due to CFTR-RD. Therefore, clinical trials to assess the effects of CFTRm for CFTR-RD are warranted, particularly for RAP where pharmaceutical treatments are lacking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorPancreatitisChloride Channel AgonistsAdultFemaleHumansMaleAcute DiseaseChildMiddle Aged

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorChloride Channel Agonists

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology, and Nutrition; College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Division of Pediatric Pulmonology; Nationwide Children's Hospital, Columb…
  • Division of Pediatric Pulmonology; Nationwide Children's Hospital, Columbus, OH, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition; University of Cincinnati Medical Center, Cincinnati, OH, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition; College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Förderung

  • Cystic Fibrosis Foundation

Zitieren

APA

Ramsey, M. L., Corzo, M., Bass, R., Lara, L. F., Hart, P. A., & Freeman, A. J. (2026). CFTR modulators reduce acute pancreatitis episodes in individuals with CFTR-related disorders: A case series. Journal of Cystic Fibrosis, 25(3), 502-503. https://doi.org/10.1016/j.jcf.2026.01.008

Vancouver

Ramsey ML, Corzo M, Bass R, Lara LF, Hart PA, Freeman AJ. CFTR modulators reduce acute pancreatitis episodes in individuals with CFTR-related disorders: A case series. Journal of Cystic Fibrosis. 2026;25(3):502-503. doi:10.1016/j.jcf.2026.01.008

BibTeX
@article{Ramsey2026,
  author = {Ramsey, Mitchell L and Corzo, Maria and Bass, Rosara and Lara, Luis F and Hart, Phil A and Freeman, A Jay},
  title = {CFTR modulators reduce acute pancreatitis episodes in individuals with CFTR-related disorders: A case series},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  volume = {25},
  number = {3},
  pages = {502--503},
  doi = {10.1016/j.jcf.2026.01.008}
}
Kostenlos starten →